The Latest Breaking News from STEM

For two years, it seemed as though China’s ruthless COVID-19 policy had paid off. After stumbling in its initial efforts to stem the pandemic, China’s rulers fixed a simple numeric target — zero COVID cases — and made sure everyone knew they had to reach it. The results looked severe…

Bengaluru

Agonizing questions are being raised by the recent tragic shooting incident in Buffalo, New York, where 18-year-old Payton S. Gendron is alleged to have shot 10 people dead and wounded three. As in the recent years’ similar acts of horror at a synagogue in Pittsburgh, a Walmart in El Paso,…

Avrobio Inc (NASDAQ:AVRO) announced preclinical data demonstrating the efficacy and safety of AVR-RD-03 gene therapy in infantile-onset Pompe disease.  Pompe disease is a lysosomal disorder caused by a mutation in the GAA gene. The lack of the enzyme encoded by GAA results in a toxic buildup of glycogen throughout the body and central nervous system.…

The World Bank said on Wednesday it will make $30 billion available to help stem a food security crisis threatened by Russia's war in Ukraine, which has cut off most grain exports from the two countries.

London South East Colleges hope to attract more candidates with the option of a compressed week

Frozen testicular tissue can still make sperm 20 years later, according to scientists who say it can help young cancer patients to later have children.

California students’ math scores have lagged for years and only gotten worse during the pandemic.

Magenta Therapeutics Inc (NASDAQ:MGTA) shared preliminary data from the Phase 1/2 dose-escalation trial of MGTA-117 in relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome with excess blasts. The data comes from a Cohort 1, evaluating the lowest dose of MGTA-117 (0.02 mg/kg). Three patients completed the safety evaluation period.  A fourth patient with…